From the Food and Drug Administration.
Nightingale
S L
SL
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000813:Anilides / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D005485:Flutamide / Q000627:therapeutic use*; D015774:Ganciclovir; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use*; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000534:rehabilitation; D011367:Professional Staff Committees; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy
D000813:Anilides; D005485:Flutamide; D015774:Ganciclovir; D008691:Methadone; D007069:Ifosfamide; D000212:Acyclovir